Voluntary nationwide recall: Betaxolol
Oct. 2023Pharmacy Updates
KVK-Tech Inc. is recalling one lot of Betaxolol tablets, USP 10 mg. This drug is used for the treatment of hypertension (high blood pressure).
KVK-Tech Inc. is recalling one lot of this drug (batch number 17853A) as a precautionary measure because a single Oxycodone HCl tablet 5 mg tablet ws found in one batch of the packaging. Betaxolol tablets have a debossed “K” above bisect “13” on one side and plain on the other side, which looks similar to Oxycodone HCL 5 mg tablets. Inadvertent exposure to a controlled substance, such as oxycodone, in specific patient populations is likely to result in significant slowing in breathing, known as respiratory depression, which is a serious health risk.
As of Sept. 29, 2023, there have been no reports of adverse events related to this recall.
Please see the table below to determine if your product has been recalled:
Product name: Betaxolol tablets USP 10 MG (NDC 10702-0013-01)
Lot number: 17853A
Expiry date:06/2027
If you have Betaxolol 10 mg tablets from this lot, you should stop using/return to place of purchase/discard.
To learn more about this recall, you can take one or more of the steps below.
KVK-Tech Inc. is recalling one lot of this drug (batch number 17853A) as a precautionary measure because a single Oxycodone HCl tablet 5 mg tablet ws found in one batch of the packaging. Betaxolol tablets have a debossed “K” above bisect “13” on one side and plain on the other side, which looks similar to Oxycodone HCL 5 mg tablets. Inadvertent exposure to a controlled substance, such as oxycodone, in specific patient populations is likely to result in significant slowing in breathing, known as respiratory depression, which is a serious health risk.
As of Sept. 29, 2023, there have been no reports of adverse events related to this recall.
Please see the table below to determine if your product has been recalled:
Product name: Betaxolol tablets USP 10 MG (NDC 10702-0013-01)
Lot number: 17853A
Expiry date:06/2027
If you have Betaxolol 10 mg tablets from this lot, you should stop using/return to place of purchase/discard.
To learn more about this recall, you can take one or more of the steps below.
- Talk to your doctor or pharmacist.
- Call KVK-Tech Inc. at 215-579-1842 Ext: 6002. TTY users should call 711. Help is available Monday through Friday from 8 a.m. to 6 p.m. EST.
- Visit the FDA website at upmchp.us/betaxolol-drugrecall.
Recent Announcements
Provider OnLine Login Changes for UPMC Employees
UPMC employees will now use their email address to access Provider OnLine. Authentication will occur through their UPMC credentials and network connections. If your UPMC email address has changed since joining the organization, you should use the email address associated with your Microsoft Teams chat account when logging in to Provider OnLine.Aug. 2026Important Notices
CME Webinar: Lifestyle Medicine in Practice: Evidence‑Based Strategies for Chronic Disease Care
Please join us for a live, CME-accredited webinar on Wednesday, Sept. 23 from noon to 1 p.m., that will provide an overview on lifestyle medicine. Participants will learn how to integrate six core domains—nutrition, physical activity, sleep, stress management, avoidance of risky substances, and social connection—into routine care using practical tools such as brief counseling, motivational interviewing, and team-based strategies.Aug. 2026Education/Webinars
CME Webinar: Getting it Right from the Start: Identifying Patient Advanced Care Directives
Please join us for a live, CME-accredited webinar on Thursday, Oct. 15, 2026 that will educate providers on identifying advanced directives and surrogate decision makers on admission.Aug. 2026Education/Webinars